AVENTYL HYDROCHLORIDE
LOE ApproachingNDAORALCAPSULE
Approved
Nov 1964
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Aventyl Hydrochloride is an oral capsule small-molecule antidepressant approved by FDA in 1964, representing a legacy tricyclic class medication. The active ingredient is nortriptyline, used historically for depression and certain anxiety disorders. It operates through monoamine reuptake inhibition, increasing synaptic availability of norepinephrine and serotonin.
LOE Approaching
Product is in late lifecycle phase with limited commercial team expansion; roles focus on defending market share against generic erosion rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Aventyl offers limited career growth potential due to mature lifecycle and zero linked job openings. The role focuses on defending legacy market position and managing generic competition rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on AVENTYL HYDROCHLORIDE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.